In literature, several papers reported that miR-145 is downregulated in thyroid cancer where it acts as a tumor suppressor by impairing cancer cell growth, cell motility, and metastasis through targeting AKT3 [59] and RAB5C [60] genes or by regulating the NF-κB pathway [61]. The gene discussed is AKT3; the disease is thyroid cancer.